GMP- und GDP-Update: 26. GMP-Konferenz
Update Arzneimittelrecht, GMP- und GDP-Update 2020, Erfahrungen mit der Fälschungsschutzrichtlinie, Green Deal, COVID-19-Gesetzgebung, Soft Skills
Tagungsberichte
Abstract
GMP and GDP Update: 26th GMP Conference: Update of Drug Law, GMP and GDP Update 2020, Experience with the Falsified Medicines Directive, Green Deal, COVID-19 Legislation, Soft Skills
The focus during the conference this year was on the topics GDP, “anti-counterfeiting directive”, COVID-19 national legislation and COVID-19 vaccine development as well as GMP and Green Deal.
Zusammenfassung
Neben dem Update zum Arzneimittelrecht gab es zudem Vorträge zu den Themen GDP, Fälschungsschutzrichtlinie, nationale COVID-19-Gesetzgebung und COVID-19-Impfstoffentwicklung sowie GMP und Green Deal.
Abstract
GMP and GDP Update: 26th GMP Conference: Update of Drug Law, GMP and GDP Update 2020, Experience with the Falsified Medicines Directive, Green Deal, COVID-19 Legislation, Soft Skills
The focus during the conference this year was on the topics GDP, “anti-counterfeiting directive”, COVID-19 national legislation and
